Corporate Symposia: Non-CME Events


Monday, July 15

Event title: It's a Matter of Time: Understanding Timely and Appropriate Intervention for Patients With Early Alzheimer’s Disease

Time: 12 - 1:45 p.m.
Location: JW Marriott Los Angeles L.A. LIVE, Platinum Ballroom
Description: Early recognition of cognitive impairment may enable timely diagnosis and initiation of appropriate interventions that may prolong patient independence and maximize treatment options and planning. This program examines barriers to and the rationale for early diagnosis by comparing two patient cases with and without timely intervention. Limited space; please RSVP.
Sponsored by: Genentech


Event title: Time Is in Our Hands; AAIC 2019 AbbVie Symposium

Time: 6 - 9 p.m.
Location: JW Marriott Los Angeles L.A. LIVE, Gold Ballroom
Description: AbbVie aspires to make a remarkable impact for patients and families affected by Alzheimer’s disease through the development of transformational treatments. We invite you to an evening of rigorous debate regarding the role of tau in primary prevention as we continue to dream, defy and disrupt Alzheimer’s disease.
Sponsored by: AbbVie

Event title: AMBAR (Alzheimer’s Management by Albumin Replacement) Phase IIb/III Results: Clinical and Biomarker Update

Time: 6 - 9 p.m.
Location: Intercontinental Los Angeles Downtown, Wiltshire Grand Ballroom, 5th Floor (shuttle bus available at 5:30, 5:40, 5:50, 6:00 p.m. from the Los Angeles Convention Center)
Description: The AMBAR study is a phase IIb/III, multicenter, randomized, blinded and placebo-controlled trial enrolling 496 mild-to-moderate Alzheimer’s disease patients. Plasma exchange with different replacement volumes of therapeutic albumin, with or without IVIG, resulted in changes in disease biomarkers levels, and improvement in cognition, language, memory and functional measures.
Sponsored by: Grifols


Tuesday, July 16

Event title: Targeted Therapy for Preclinical Alzheimer’s Disease

Time: 12 - 1:45 p.m.
Location: JW Marriott Los Angeles L.A. LIVE, Platinum Ballroom A-D
Description: An interactive symposium focusing on the rationale and opportunities for drug development for preclinical Alzheimer’s disease. Our expert faculty will review the pathophysiologic pathways underlying AD, discuss the Aβ/Tau/Neurodegeneration (A/T/N) system for classifying AD biologically and outline approaches for clinical trials in preclinical AD.
Sponsored by: Eisai

Event title: Understanding the Impact and Consequences of Delusions and Hallucinations in Dementia-Related Psychosis from the Neurologist, Psychiatrist and Caregiver Perspectives

Time: 6 - 9 p.m.
Location: JW Marriott Los Angeles L.A. LIVE, Gold Ballroom
Description: This symposium will provide an overview of dementia-related psychosis with a focus on understanding the impact and consequences of delusions and hallucinations on families. Expert faculty will have an interactive discussion to advance the audience’s knowledge on neurobiology and considerations when approaching the neuropsychiatric symptoms in dementia-related psychosis.
Sponsored by: Acadia Pharmaceuticals

Event title: Unraveling the Central Role of Amyloid in Alzheimer’s Disease

Time: 6:30 - 8 p.m.
Location: Intercontinental Los Angeles Downtown, Hollywood Ballroom, 7th floor
Description: During this symposium, a panel of renowned experts will highlight the latest biological and genetic research findings, address uncertainties and discuss evidence surrounding the central role of amyloid as the initiating event in Alzheimer’s disease.
Sponsored by: Amgen Novartis

Data on file USA-CBU-80295, M-NSF-1375324 6/19

Join the Conversation #AAIC22






News & Videos

Press Room

Contact Us

> 1200px
> 992px
> 768px
< 767px